LIV001

DRUG2 trials

Sponsors

Liveome Inc.

Conditions

Ulcerative ColitisUlcerative Colitis (UC)

Phase 1

A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)

CompletedNCT05975047

Liveome Inc.Ulcerative Colitis

Start: 2023-09-24End: 2024-03-05Updated: 2024-12-20

LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)

Not yet recruitingNCT06749795

Liveome Inc.Ulcerative Colitis (UC)

Start: 2025-03-24End: 2026-03-24Target: 15Updated: 2025-03-24